2025 was a watershed year for gold, which set new highs as its safe-haven appeal increased. As global uncertainty intensified,…
The U.S. Food and Drug Administration (FDA) refused to consider Moderna’s application for a new flu vaccine using mRNA technology,…
Astral Resources NL (ASX: AAR) (Astral or the Company) is pleased to report assay results received from a 17-hole reverse…